chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The Chief Complaint is: 40 y/o F with history of allergic rhinitis including systemic reaction to skin testing years ago presents for COVID vaccination.  She and I discussed getting vaccinated with her history a few weeks ago and I recommended vaccination.  She reports that today she is in previous good health but 15 minutes after vaccination she started to feel itching all over her body which was rapidly followed by throat itching and difficulty swallowing.  She was taken to the treatment area of the vaccination center and evaluated. - Pruritis, flushing, sclerae injection after COVID vaccination with PFizer vaccine.  May be allergic or due to complement release.    Treatment course -  took patient back to the treatment area and administered 0.3mg epinephrine with rapid improvement in symptoms and signs and minimal side effects. Follow up BP lower, flushing improved, sclerae improved and throat symptoms improved. Called 911 for EMS response to observe her in the ED will complete VAERS and contact patient by phone for follow up
STRESS, HIGH CHOLESTEROL, HEARING AND VISUAL DISORDERS, HEADACHE, HAIR LOSS, SLEEPING PROBLEM.
devel fever, loss of appetite on 24NOV96;took only 3oz formula over 36hr;was limp, pale & had high pitched cry that was unconsolable for 3-4hr;hosp on 25NOV96 for 4d;spinal tap negative;had IV & was given IV ATB;fever up to 104;
Got vaccine at Clinic. Called to report her issues as was told to contact PCP.  Was seen in office on 1/20/2021.  She states arm sore the first 2 days.  On 1/15 she noticed an erythematous round area at site of injection.  Over the weekend she felt extremely fatigued, and some dizziness.  She still feels tired and the erythema and warmth as increased to 3 in by 4 in over left deltoid.  Denies fever, chills, swelling in mouth or throat , no SOB.  Provider reviewed information from Moderna site with people in the original trial developed a delayed injection site similar to patients after day 8.  Area on deltoid was outlined and patient instructed to  return to clinic if site  increases in size or induration.  Informed to report to ER if any swelling, hives, throat swelling or difficult breathing occurs.
Slight tingling numbness in my mouth upper root. Upon leaving pharmacy. So that?s 25 minutes after first shot. Then tongue had a slight taste within hours back of neck by skull was sore day 3  still is. Feels like my lymph nodes may be working.
1st dose of shingrix on 3/6/2021, 2nd on 4/13/2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number 44XX4, expiry date 27th May 2023) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 6th March 2021).   On 13th April 2022, the patient received the 2nd dose of Shingrix. On 13th April 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 09-JUN-2022 Reporter's Comment: No reactions reported. The reporter consented to follow up by email. Additional Supportive Information: The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule.
Red blotching rash around IPV injection site small area of redness around Dapt injection site. Local erythematous reaction to IPV
extreme tiredness set in about 4 1/2 hours after injection.  Sore arm.  Body became achy/ joint pain/ chills.  This lasted about 24 hours.  2 1/2 days after injection, started to become light headed and dizzy when standing up / bending over.  Symptoms increased on day 3, including mild nausea.  Experienced sinus pressure and headache.  Day 4 (today) symptoms are starting to subside, but still experiencing some dizziness.
Sharp chest pains like a knife to heart came when she lifted light groceries,  drove or hit a ball in backyard.    And after dinner.  Went away after i said do nothing just rest.
no adverse effects reported; one female patient was administered improperly stored M-M-R II; This spontaneous report was received from an office manager and refers to a 26-year-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 31-JUL-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # R031628 has been verified to be a valid lot number, expiration date 01-NOV-2020, recombinant Human albumin (exact dose, dose number, route and site of administration were not reported) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent.  Administered doses of vaccine were exposed to the temperature excursion above (also reported as the highest temperature) 47 degrees Fahrenheit (51.1 degrees Fahrenheit, multiple) total time for 29 hours. Data logger was involved. There was no previous temperature excursions. There was no adverse effects reported.
Sore arm; swollen/tender lymph nodes in armpit of injection arm; swollen/tender lymph nodes in armpit of injection arm; headache; chills; fatigue; This is a spontaneous report from a contactable nurse (patient). A 29-year-old female patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3249 and expiry date: unknown), intramuscular left arm on 10Jan2021 09:45 at single dose for COVID-19 immunisation. The patient medical history was not reported. Patient was not pregnant. Concomitant medication included melatonin, ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS). Patient took the 1st dose (lot number: EL4284) on intramuscular left arm on 23Dec2020 10:15. The patient experienced sore arm, swollen/tender lymph nodes in armpit of injection arm, headache, chills, fatigue on 10Jan2021 19:30. Outcome of the events was recovering. No treatment was given for the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from an office manager and refers to a 12 month-old patient of unknown gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history reported. On 01-NOV-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with an expiration date on 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. No data logger was involved. This is one of several reports from the same source. Additional information has been requested.
Information has been received from a registered nurse referring to unspecified number of patients of unknown age and gender. The patients' medical history and drug allergies were not reported. On unknown dates the patients were vaccinated with improperly stored RECOMBIVAX HB (lot# K005078 with expiration date of 01-APR-2016, lot# reported as "K020218" with expiration date 24-OCT-2016) (dose and route unknown). No adverse effects reported. No product quality complaints (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
On 12/27 started having congestion and irritated sore throat. Then fatigue set in. On 12/28 tested positive on at home test. Took NYQUIL and DAYQUIL provided minor relief. Developed persistent cough. Ran fever of 100.9 with TYLENOL. Took SUDAFED for congestion. 12/29 had telehealth visit with PCP. Was prescribed PAXLOVID but didn't take it. Was prescribed TESSALON PEARLS for cough and they really helped. Symptoms began resolving the 12/30 no fever. 12/31 worst of the symptoms resolved but lost entire sense of smell and most of taste. 01/02/2023 smell began to return. 01/03/2023 smell and taste mostly returned 01/04/2023 still having congestion and occasional cough.
Arm is red around injection site; Puffy around injection site; Pain at injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Arm is red around injection site), VACCINATION SITE SWELLING (Puffy around injection site) and VACCINATION SITE PAIN (Pain at injection) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Arm is red around injection site), VACCINATION SITE SWELLING (Puffy around injection site) and VACCINATION SITE PAIN (Pain at injection). At the time of the report, VACCINATION SITE ERYTHEMA (Arm is red around injection site), VACCINATION SITE SWELLING (Puffy around injection site) and VACCINATION SITE PAIN (Pain at injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
This case was reported by a physician and described a 63 year old male pt who received Engerix-B and subsequently tested positive for hepatitis B surface antigen. On 2/5/04, prior to immunization with Engerix-B, the pt tested negative for hepatitis B surface antibody. On 8/24/04, the pt received the 1st dose of Engerix-B (lot AHBVA077AB). Approximately 4 days later, on 8/28/04, the pt tested positive for hepatitis B surface antigen. The physician considered the event to be related to vaccination with Engerix-B.
Red blotchy skin around chest/neck area. Difficulty breathing immediately after PPV injection. Flu injection administered at around 8am. Returned same day after 10:30 for pneumonia vaccine
Received 1st Vaccine on March 18th at 3:45pm.  At 9pm, noticed sore arm and tired.  Next day at 9:45am was week, not clear thinking, chills, muscle aches, headache, tired.  Symptoms worsened throughout the day.  Sever chills, throwing up, increased headache, and muscle aches, then later fever.  Was taken to urgent care as temperature wasn't decreasing.  At urgent care, they gave me a COVID-19 and flu test - both negative.  Continued on Tylenol and ibuprofen.  Symptoms continued over the next 3 days to a slight lesser degree.  Continue to have adverse symptoms (headache, weakness, brain fog, and tired) and it has been 13 days.  the last 2 days, i has just towards the evening when i 'hit the wall' with the symptoms and have to lay down for the rest of the night.
Patient with vascular rash that was painful and itchy on bilateral upper legs. Had similar reaction after 1st gardasil but rash was on ankle.
Suspected vaccination failure; Had a severe case; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got severe shingles. The patient stated that, they did not work. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
psoriasis; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NUS2023US001532_NC.  An 80-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PSORIASIS (non-serious), outcome "unknown".  Additional information: Patient stated she started getting psoriasis after getting the covid shot.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
2/4/12. 8:30 am Red blistery area noted next to (R) deltoid upper injection site - c/o itching 2:30 pm. Rash noted from injection site across chest toward neck area 2/5/12- Rash darker red, itching continues 2/6/12 - rash remains with itching - 8:30 am - BENADRYL given 10:30 am - Rash fading, itching subsiding.
Patient stated that on 11/2/08 the day after the vaccine given that she had swollen lips and scratchy throat for approximately 2 hrs. -went away with no treatment necessary
Pt requested FluMist.  Nurse gave the FluMist then realized pt was over 49 yrs old.    No adverse reactions known.
My estimated date of delivery is 05/18/2023, so I was around 5 weeks pregnant at the time of the vaccine but was unaware of my pregnancy status. I believe I was exposed to COVID-19 on 10/14/2022, I was on vacation with my husband, and we were told someone was positive the next day. I began to notice a sore throat on 10/20/2022. By 10/21/2022, I was running a fever no higher than 100.7. I had aches and chills as well. That continued through the weekend. After that, I had very severe congestion for a few weeks. Around 11/03/2022, I called in for a telehealth appointment and was prescribed a steroid inhaler to help with my cough and congestion. By around 11/09/2022, my symptoms were basically gone.
Migraine, heavy sweating, body aches, muscle aches, joint pain, nausea, fatigue
Complains of severe bodily itching and fine reddened rash with flushing and mild chest tightness. No wheezing or stridor. No c/o throat swelling. Given 50mg BENADRYL IM and evaluated by Medical Provider. Sent home w/co-worker and RX for PO BENADRYL and PEPCID.
LIKE SOMETHING CRAWLING IN BLOOD; NAUSEA; MUSCLES ACHES; INJECTION SITE PAIN (IN LEFT ARM); SWELLING OF THE ARM; BURNING SENSATION IN THE LEFT ARM; ACHES AND PAINS; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, and venous insufficiency, and other pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced aches and pains. On 09-APR-2021, the subject experienced swelling of the arm. On 09-APR-2021, the subject experienced burning sensation in the left arm. On 09-APR-2021, the subject experienced injection site pain (in left arm). On 10-APR-2021, the subject experienced like something crawling in blood. On 10-APR-2021, the subject experienced nausea. On 10-APR-2021, the subject experienced muscles aches. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from like something crawling in blood, nausea on 12-APR-2021, and muscles aches on 11-APR-2021, had not recovered from injection site pain (in left arm), and the outcome of swelling of the arm, burning sensation in the left arm and aches and pains was not reported. This report was non-serious.; Sender's Comments: Medical assessment comment not required as per standard procedure as case was assessed as non-serious.
Headache, achy all over, developed cellulitis at injection  site. Given antibiotics 2x?s daily for 10 days.
Breakthrough infection; Breakthrough infection/COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adolescent female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "Breakthrough infection"; COVID-19 (medically significant), outcome "unknown", described as "Breakthrough infection/COVID-19 confirmed by positive COVID-19 test". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Clinical Course: It was unknown whether the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown that the patient was diagnosed with COVID-19 with Covid-19 prior to vaccination, but was tested since the vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
TWO DIFFERENT MANUFACTURE SERIES, MODERNA 3/6/21, PFIZER 4/20/21.
This patient was under hospice care at home with Nursing Service and Hospice. He received the J&J vaccination at noon by local public health nurse on Mon 4/12/21. The patient's wife, reported to hospice team that he had been sleepy during the day and had received a dose of Ativan  earlier that morning (PRN medication at 0750). The primary hospice nurse reported wife noted he became more lethargic throughout the day after vaccination with his condition worsening at 1720; at that time his blood sugar levels were noted to be low at "47" but patient was alert enough to drink orange juice, eat ice cream. The patient continued to deteriorate so MD was consulted and he was transported to the ED where he later expired at 1930.
I have had progressive peripheral neuropathy for two years.  No known cause after all typical causes have been checked (diabetes, B12 deficiency, renal issues, tumors, etc.), so idiopathic.  Still fairly low level in terms of symptoms, maybe 2 on the 10 scale.  About 24 hours after the second dose, the symptoms of my PN got noticeably worse all of a sudden, up to maybe 3 or 4 on a 10 scale, and have stayed at that level for four days at this point.
This spontaneous report was received from a other health professional (nurse practitioner) refers to a patient of unknown demographics. Patient's pertinent medical history and drug allergies were not reported. On 30-APR-2014 the patient was vaccinated with first dose of GARDASIL (dose, frequency, lot # and expiration date not reported). In November 2014 (unknown date) patient went to the office to receive a second dose of GARDASIL. No concomitant therapy was reported. No adverse symptoms were reported. No product quality complaint (PQC) was reported. Outcome of the events were not reported. Causality assessment was not provided. Additional information has been requested.
From May 15th until today. Extreme joint and muscle paint throughout body. Nausea, dizziness.
Immediate blurring of vision, weak, flu-like symptoms, fever, lethargic.
Case number PHEH2012US025644 is an initial spontaneous report received from a medical assistant on 28 Dec 2012. This report refers to a 74-year-old female patient. Her medical history and concomitant medication was not reported. She was vaccinated with FLUVIRIN (batch number: 1206101) intramuscularly on 03 Oct 2012. Two days later on 05 Oct 2012, she began to experience left arm and shoulder pain. She explained pain as a burning sensation that radiates away from the injection site and that her bones in the area are also painful. At the date of reporting, the events are ongoing. Reporter stated that she was refused to a physician for follow-up but she was refusing to go because the patient insists that her pain is due to the vaccine. The seriousness and causality of the events was not reported.
Extreme fatigue, back, hip and neck pain Dizziness Headache Muscle aches in upper legs
12 yo female here for 2nd HPV. Administered to patient by IM M (L) thigh, pt lying on bed. Pt was instructed to lie for 15-30 min, sipping juice. 12 min called about pt passed out on BR floor. Mom took her to BR 8-10 min later needed to go badly. Mom stayed with pt as she stood up from toilet, turned pale, shuddered, blacked out, mom supported her through the fall. LOC was momentary. Pt was pale & diaphoretic 5 min later walked to bed.
Immediately upon vaccination pt had sharp pain in elbow, wrist, and fingers. Pt took tylenol and motrin, applied cold and hot packs, and massage therapy all with little relief.  Pain remains constant and increases with movement.
Patient initially had Johnson/Johnson vaccine for primary immunization, followed by a moderna booster of 0.25ml in January 2022. The patient asked for a second moderna booster and this was given 6 months later but he was given 0.50ml of a vial that indicated a booster dose should have been 0.25ml. The patient reported fatigue and sore arm about 2 hours after the vaccine was given at 11am on 6/6/22. He was instructed to call if any further symptoms occurred.
Varicella - Information has been received from a physician concering a 5 year old male patient who on 14 May 1998 was vaccianted in the right lateral thigh with a first dose of varicella virus vaccine live (lot 625379/0308H).  There were no illnesses at the time of vacciantion.  On 02 Apr 2000 the patient developed chickenpox and was soon in the physican's office on 03 Apr 2000.
Information has been received from a physician concerning a 27 year old female with a family history of eczema and no drug allergies, who on 18-SEP-2007 was vaccinated intramuscularly with a 0.5mL first dose of Gardasil.  The patient was vaccinated with a second dose of Gardasil (Lot# 659441/1446U).  Concomitant therapy included ORTHO TRI-CYCLEN LO.  Subsequently, "three weeks after the second dose" the patient developed eczema near her eyes and arms.  The patient had no reaction after the first dose.  The patient was seen by the physician.  A complete blood cell count was performed and the patients neutrophil and eosinophil counts were low.  At the time of the report, the patient had not recovered.  No product quality complaint was involved.  Additional information has been requested.
Patient woke up with a bad headache at 4am 5/14/21,  she took usual meds for her migraines and several hours later her headache was no better.  Her mom who reported this to me didn't know what her migraine meds were.  She did say the headache was more severe than she usually gets (gets migraines approx 10x/month normally).  I recommended she call her migraine doctor to ask their opinion.  If she feels she needs to see a doctor at ER or urgent care due to the severity of the heachache that is also an option.  I told her heachaches were normal with the Janssen vaccine (30-44%) but I wasn't sure if her migraine condition would contribute to the severity of the headache she was having. I followed up with patient today 5/15 to see if improved by no answer, I left a voice mail for her to call me back.